Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Palliation
Do you modify the whole brain radiation dose if a patient has previously been treated with SRS for brain metastases?
Related Questions
Do you use a comprehensive volumetric, rather than numeric, cutoff in consideration of SRS vs WBRT for brain metastases?
Would you offer SRS to a hippocampal metastasis in a patient with ES-SCLC treated with prior WBRT?
Would you offer 12-16 Gy in a single fraction for a symptomatic, non-vertebral bone metastasis?
What screening tools or signs do you use to predict if a cancer patient is near end-of-life?
What normal tissue dose constraints do you use when delivering up to 3 cycles of the palliative quad shot regimen for gynecologic pelvic malignancies?
How would you manage a patient with a high-risk asymptomatic bone metastasis with a driver mutation?
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
Would you consider spine re-irradiation after Pluvicto?
Does your choice of dose and fractionation for bone metastasis depend on the location of the metastasis in question?
Is it safe to re-irradiate non-spine bone metastases with SBRT if they received previous SBRT?
